Are you 65 or older? Get two vaccinations against pneumonia

Translate to Spanish or other 102 languages!

Older adults who received pneumococcal conjugate vaccine (PCV13), which prevents acquisition of certain pneumococcal strains experienced 35% lower risk of COVID 19 diagnosis. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Gregory Curfman, MD, Assistant Professor of Medicine, Former Editor-in-Chief, Harvard Health Publishing

If you or a loved one is age 65 or older, getting vaccinated against pneumonia is a good idea — so good that the Centers for Disease Control (CDC) recommends that everyone in this age group get vaccinated against pneumonia twice.

This new recommendation is based on findings from a large clinical trial called CAPiTA, which were published in The New England Journal of Medicine.

- Advertisement -

Streptococcus pneumoniae, sometimes just called pneumococcus, is a common bacterium that can cause serious lung infections like pneumonia. It can also cause invasive infections of the bloodstream, the tissues covering the brain and spinal cord (meningitis), and other organs and tissues. Older individuals are especially prone to being infected by Pneumococcus, and these infections are often deadly. While the recently authorized COVID-19 vaccines remain the most important strategy for preventing COVID-19, investigators found that older adults who received pneumococcal conjugate vaccine (PCV13), which prevents acquisition of certain pneumococcal strains experienced 35% lower risk of COVID 19 diagnosis than adults who did not receive the PCV13 vaccine (March 10, 2021).

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -